DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Dicerna Pharmaceuticals, Inc. (DRNA)
« Back to company indexDRNA Chatter Timeline
Stock Ticker for DRNA
Most Active Tweeters for DRNA
| User | Tweets |
|---|---|
| @AmericanBanking | 7 |
| @TickerReport | 5 |
| @TekATL3 | 4 |
| @IRAMarketReport | 3 |
| @ZolmaxNews | 3 |
Recent Tweets for DRNA
 |
@mikegoodma $DRNA gets BTD for PH1. FDA adds that PH2 + PH3 meet its criteria for BTD, and DRNA will continue discussions w FDA… https://t.co/fYHGlzV4AU July 15th 2019, 2:07pm |
 |
@portefeuillefun RT @RNAiAnalyst: $DRNA Breakthrough Therapy Designation for DCR-PHXC for type 1 primary hyperoxaluria (but not types II+III): https://t.co/… July 15th 2019, 12:07pm |
 |
@MarketCurrents $DRNA - Dicerna's DCR-PHXC a Breakthrough Therapy for rare kidney disorder https://t.co/qz9Bj1PsDs July 15th 2019, 12:07pm |
 |
@AmericanBanking Dicerna Pharmaceuticals $DRNA Rating Reiterated by HC Wainwright https://t.co/GMoHkPaxpO #stocks July 15th 2019, 11:07am |
 |
@AlertTrade RT @Briefingcom: $DRNA: Dicerna Pharmaceuticals: FDA has granted a Breakthrough Therapy Designation to DCR-PHXC for the treatment of... htt… July 15th 2019, 9:07am |
 |
@Briefingcom $DRNA: Dicerna Pharmaceuticals: FDA has granted a Breakthrough Therapy Designation to DCR-PHXC for the treatment of… https://t.co/zdluJqzSK5 July 15th 2019, 9:07am |
 |
@biostockinfo RT @BioBreakout: $DRNA Dicerna Pharma Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of PH1 July 15th 2019, 8:07am |
 |
@InsiderBiotech $DRNA Dicerna Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of Primary Hyperoxaluria Type 1 July 15th 2019, 7:07am |
 |
@RNAiAnalyst $DRNA Breakthrough Therapy Designation for DCR-PHXC for type 1 primary hyperoxaluria (but not types II+III): https://t.co/Pd3Jae3LDy $ALNY July 15th 2019, 7:07am |
 |
@NewsToDesk $DRNA: Dicerna Receives Breakthrough Therapy Designation for DCR …: https://t.co/VphDDnsQkB July 15th 2019, 7:07am |
 |
@ToothFrank $DRNA Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of Primary Hyperoxaluria Type 1 (PH1) July 15th 2019, 7:07am |
 |
@BioBreakout $DRNA Dicerna Pharma Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of PH1 July 15th 2019, 7:07am |
|
@TekATL3 $DRNA breakthrough designation news July 15th 2019, 7:07am |
 |
@TraderTexMex RT @BioStocks: $DRNA Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of Primary Hyperoxaluria Type 1 (PH1) July 15th 2019, 7:07am |
|
@TekATL3 $DRNA got to 16.90, like the longer term chart https://t.co/LHOtzBBqm3 July 14th 2019, 3:07pm |
 |
@bbnsnews Head to Head Analysis: Horizon Therapeutics $HZNP versus Dicerna Pharmaceuticals $DRNA https://t.co/fVGSJ6RqCb July 14th 2019, 5:07am |
 |
@ThisLincolnian Head to Head Analysis: Horizon Therapeutics $HZNP versus Dicerna Pharmaceuticals $DRNA https://t.co/5mLHku1yw6 July 14th 2019, 5:07am |
|
@dakotafinancial Brokerages Expect Dicerna Pharmaceuticals Inc $DRNA Will Post Quarterly Sales of $10.95 Million https://t.co/GVRnDA3v0Z July 13th 2019, 6:07pm |
 |
@1MinuteStock Explore #fundamental numbers and pros and cons for $DRNA https://t.co/jTa5imTE13 July 13th 2019, 10:07am |
 |
@Gambiste1 RT @TradeFlags: TD BUY $DRNA at 14.20, Supp 14.20 Resis 15.83 R11 HiLo 56% T1Y 22 buy 1.7 fwdPE -10.2 DIV N/A #Dicerna Ph #stocks #trading… July 13th 2019, 2:07am |
 |
@TradeFlags TD BUY $DRNA at 14.20, Supp 14.20 Resis 15.83 R11 HiLo 56% T1Y 22 buy 1.7 fwdPE -10.2 DIV N/A #Dicerna Ph #stocks… https://t.co/9Wa7Dk8Ykr July 13th 2019, 12:07am |
 |
@xiscan1 RT @SeekingAlpha: $DRNA - Dicerna: An RNA Therapy-Based 21st Century Likely Winner https://t.co/KE9Ra2KjwB July 12th 2019, 1:07am |
 |
@SeekingAlpha $DRNA - Dicerna: An RNA Therapy-Based 21st Century Likely Winner https://t.co/KE9Ra2KjwB July 12th 2019, 1:07am |
 |
@TickerReport $10.95 Million in Sales Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/bemMsYN6H1 July 11th 2019, 11:07am |
|
@TickerReport Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Earnings of -$0.32 Per Share https://t.co/VttO7ObMNd July 11th 2019, 11:07am |
 |
@ZolmaxNews Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Earnings of -$0.32 Per Share https://t.co/Nn4DARrRYv July 11th 2019, 11:07am |
|
@TekATL3 $DRNA possible pullback to 12.60ish area. July 10th 2019, 7:07pm |
 |
@ChartMill $DRNA has an excellent technical rating and also presents a decent setup pattern. https://t.co/FeWeCr9eKr https://t.co/GDCJKAsATT July 10th 2019, 6:07pm |
 |
@IRAMarketReport Analysts Anticipate Dicerna Pharmaceuticals Inc $DRNA Will Post Earnings of -$0.32 Per Share https://t.co/ie67sk6HpK #markets July 9th 2019, 10:07am |
 |
@chaffeybreeze Analysts Anticipate Dicerna Pharmaceuticals Inc $DRNA Will Post Earnings of -$0.32 Per Share https://t.co/TOhuonj63X #stocks July 9th 2019, 10:07am |
 |
@WatchlistN Dicerna Pharmaceuticals $DRNA Cut to “Hold” at BidaskClub https://t.co/TzygTYbL8Y July 7th 2019, 2:07am |
|
@AmericanBanking Reviewing Horizon Therapeutics $HZNP and Dicerna Pharmaceuticals $DRNA https://t.co/r2StZnttjw #stocks July 7th 2019, 2:07am |
|
@TickerReport B. Riley Analysts Give Dicerna Pharmaceuticals $DRNA a $24.00 Price Target https://t.co/oiYR6vCYte July 7th 2019, 2:07am |
|
@bbnsnews Citigroup Boosts Dicerna Pharmaceuticals $DRNA Price Target to $30.00 https://t.co/EM90RwNbeT July 7th 2019, 1:07am |
 |
@midetimes Citigroup Raises Dicerna Pharmaceuticals $DRNA Price Target to $30.00 https://t.co/p3TUC9xwMt #stocks July 6th 2019, 7:07am |
 |
@dailymailtimes Citigroup Raises Dicerna Pharmaceuticals $DRNA Price Target to $30.00 https://t.co/xLFkn8kwIs #investing July 6th 2019, 7:07am |
 |
@dailypoliticaln Citigroup Raises Dicerna Pharmaceuticals $DRNA Price Target to $30.00 https://t.co/xdNYjwD1rn July 6th 2019, 7:07am |
 |
@ConsumerFeed Citigroup Raises Dicerna Pharmaceuticals $DRNA Price Target to $30.00 https://t.co/eGOuLtsY9y July 6th 2019, 7:07am |
|
@ConsumerFeed Dicerna Pharmaceuticals $DRNA Cut to Hold at BidaskClub https://t.co/RjO0394t3Y July 6th 2019, 7:07am |
|
@IRAMarketReport Dicerna Pharmaceuticals $DRNA Cut to Hold at BidaskClub https://t.co/DEoLQcVizb #markets July 6th 2019, 7:07am |
|
@chaffeybreeze Dicerna Pharmaceuticals $DRNA Cut to Hold at BidaskClub https://t.co/obJeBKaTgm #stocks July 6th 2019, 7:07am |
 |
@macondailynews Dicerna Pharmaceuticals $DRNA Rating Reiterated by Cowen https://t.co/DhoDTfg2Ij July 6th 2019, 4:07am |
|
@AmericanBanking $10.95 Million in Sales Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/b8esOAjIM2 #stocks July 6th 2019, 1:07am |
|
@WatchlistN Dicerna Pharmaceuticals $DRNA PT Set at $24.00 by B. Riley https://t.co/szOhGmAEXQ July 5th 2019, 8:07pm |
|
@ZolmaxNews Dicerna Pharmaceuticals $DRNA PT Set at $24.00 by B. Riley https://t.co/2pC6LQzMDd July 5th 2019, 8:07pm |
|
@midetimes Dicerna Pharmaceuticals $DRNA Given a $24.00 Price Target at B. Riley https://t.co/NZ7LnPuTGA #stocks July 5th 2019, 8:07pm |
|
@dailymailtimes Dicerna Pharmaceuticals $DRNA Given a $24.00 Price Target at B. Riley https://t.co/QWnJzl1732 #investing July 5th 2019, 8:07pm |
|
@dailypoliticaln Dicerna Pharmaceuticals $DRNA Given a $24.00 Price Target at B. Riley https://t.co/iOPcJgSwmZ July 5th 2019, 8:07pm |
|
@ThisLincolnian Dicerna Pharmaceuticals $DRNA Given a $24.00 Price Target by B. Riley Analysts https://t.co/fTwcHYF6iM July 5th 2019, 8:07pm |
 |
@OlympiaReport Dicerna Pharmaceuticals $DRNA Given a $24.00 Price Target by B. Riley Analysts https://t.co/jh5BLDWwyY July 5th 2019, 8:07pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.